Bridgewater Associates (Ray Dalio) — GSK Trade History
Quarter-by-quarter changes in the GSK PLC position · CUSIP 37733W204
Currently held · 4 YearsFirst seen: 2022 Q3split-adjusted
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-14 | Reduce | 504,171 | -194,495 | -27.8% | $26.4M | 0.11% |
| 2026 Q1 | 2026-05-15 | Reduce | 698,666 | -717,859 | -50.7% | $38.6M | 0.17% |
| 2025 Q4 | 2026-02-13 | Add | 1,416,525 | 14,770 | +1.1% | $69.5M | 0.25% |
| 2025 Q3 | 2025-11-13 | Add | 1,401,755 | 57,713 | +4.3% | $60.5M | 0.24% |
| 2025 Q2 | 2025-08-13 | Add | 1,344,042 | 140,947 | +11.7% | $51.6M | 0.21% |
| 2025 Q1 | 2025-05-14 | Reduce | 1,203,095 | -1,044,596 | -46.5% | $46.6M | 0.22% |
| 2024 Q4 | 2025-02-13 | Add | 2,247,691 | 1,281,855 | +132.7% | $76.0M | 0.35% |
| 2024 Q3 | 2024-11-13 | Add | 965,836 | 500,010 | +107.3% | $39.5M | 0.22% |
| 2024 Q2 | 2024-08-14 | Add | 465,826 | 330,532 | +244.3% | $17.9M | 0.09% |
| 2024 Q1 | 2024-05-14 | Reduce | 135,294 | -78,726 | -36.8% | $5.8M | 0.03% |
| 2023 Q4 | 2024-02-14 | Add | 214,020 | 35,982 | +20.2% | $7.9M | 0.04% |
| 2023 Q3 | 2023-11-13 | Reduce | 178,038 | -13,099 | -6.9% | $6.5M | 0.04% |
| 2023 Q2 | 2023-08-11 | Add | 191,137 | 36,485 | +23.6% | $6.8M | 0.04% |
| 2023 Q1 | 2023-05-12 | Add | 154,652 | 21,674 | +16.3% | $5.5M | 0.03% |
| 2022 Q4 | 2023-02-13 | Add | 132,978 | 45,317 | +51.7% | $4.7M | 0.03% |
| 2022 Q3 | 2022-11-10 | New | 87,661 | 87,661 | — | $2.6M | 0.01% |
| 2022 Q2 | 2022-08-11 | — | — | — | — | — | — |
| 2022 Q1 | 2022-05-13 | — | — | — | — | — | — |
| 2021 Q4 | 2022-02-14 | — | — | — | — | — | — |
| 2021 Q3 | 2021-11-12 | — | — | — | — | — | — |
| 2021 Q2 | 2021-08-13 | — | — | — | — | — | — |
| 2021 Q1 | 2021-05-14 | — | — | — | — | — | — |
| 2020 Q4 | 2021-02-12 | — | — | — | — | — | — |
| 2020 Q3 | 2020-11-13 | — | — | — | — | — | — |
| 2020 Q2 | 2020-08-12 | — | — | — | — | — | — |
| 2020 Q1 | 2020-05-14 | — | — | — | — | — | — |
| 2019 Q4 | 2020-02-13 | — | — | — | — | — | — |
| 2019 Q3 | 2019-11-13 | — | — | — | — | — | — |
| 2019 Q2 | 2019-08-13 | — | — | — | — | — | — |
| 2019 Q1 | 2019-05-14 | — | — | — | — | — | — |
| 2018 Q4 | 2019-02-13 | — | — | — | — | — | — |
| 2018 Q3 | 2018-11-13 | — | — | — | — | — | — |
| 2018 Q1 | 2018-08-13 | — | — | — | — | — | — |
| 2018 Q2 | 2018-08-13 | — | — | — | — | — | — |
| 2017 Q4 | 2018-02-13 | — | — | — | — | — | — |
| 2017 Q3 | 2017-11-13 | — | — | — | — | — | — |
| 2017 Q2 | 2017-08-10 | — | — | — | — | — | — |
| 2017 Q1 | 2017-05-11 | — | — | — | — | — | — |
| 2016 Q4 | 2017-02-10 | — | — | — | — | — | — |
| 2016 Q3 | 2016-11-09 | — | — | — | — | — | — |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.